Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Sun Pharmaceutical Industries Inc recalls DOXOrubin Hydrochloride Liposome injection

Class Iofficial

FDA Class I

FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.

Hazard
Presence of Particulate matter: Particulate matter identified as glass.
Products
  • DOXOrubin Hydrochloride Liposome injection
Where it was sold

U.S. Nationwide

Nationwide

Units affected
675 vials
About this recall
DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol, Gujarat, India, NDC 72603-200-01.